---
keywords:
  - Systematic Review
  - Information Retrieval
  - Endometriosis Recurrence
  - GnRH Agonists
category: cs.CL
publish_date: 2025-09-23
arxiv_id: 2509.16599
---

<!-- KEYWORD_LINKING_METADATA:
{
  "processed_timestamp": "2025-09-24T03:15:14.162818",
  "vocabulary_version": "1.0",
  "selected_keywords": [
    "Systematic Review",
    "Information Retrieval",
    "Endometriosis Recurrence",
    "GnRH Agonists"
  ],
  "rejected_keywords": [],
  "similarity_scores": {
    "Systematic Review": 0.8,
    "Information Retrieval": 0.78,
    "Endometriosis Recurrence": 0.82,
    "GnRH Agonists": 0.79
  },
  "extraction_method": "AI_prompt_based",
  "budget_applied": true,
  "candidates_json": {
    "candidates": [
      {
        "surface": "systematic review",
        "canonical": "Systematic Review",
        "aliases": [
          "evidence synthesis",
          "review process"
        ],
        "category": "specific_connectable",
        "rationale": "Systematic reviews are a cornerstone of evidence-based medicine and connect to various research methodologies.",
        "novelty_score": 0.45,
        "connectivity_score": 0.88,
        "specificity_score": 0.7,
        "link_intent_score": 0.8
      },
      {
        "surface": "information retrieval",
        "canonical": "Information Retrieval",
        "aliases": [
          "data retrieval",
          "literature search"
        ],
        "category": "broad_technical",
        "rationale": "Information retrieval is crucial for processing large datasets, linking to computational methods in research.",
        "novelty_score": 0.4,
        "connectivity_score": 0.85,
        "specificity_score": 0.65,
        "link_intent_score": 0.78
      },
      {
        "surface": "endometriosis recurrence",
        "canonical": "Endometriosis Recurrence",
        "aliases": [
          "disease recurrence",
          "endometriosis relapse"
        ],
        "category": "unique_technical",
        "rationale": "This specific medical condition is central to the study and connects clinical findings with computational methods.",
        "novelty_score": 0.75,
        "connectivity_score": 0.6,
        "specificity_score": 0.85,
        "link_intent_score": 0.82
      },
      {
        "surface": "gonadotropin-releasing hormone agonists",
        "canonical": "GnRH Agonists",
        "aliases": [
          "GnRH-a",
          "hormone therapy"
        ],
        "category": "unique_technical",
        "rationale": "GnRH agonists are a key treatment in the study, linking pharmacological interventions with clinical outcomes.",
        "novelty_score": 0.7,
        "connectivity_score": 0.65,
        "specificity_score": 0.8,
        "link_intent_score": 0.79
      }
    ],
    "ban_list_suggestions": [
      "workflow",
      "method"
    ]
  },
  "decisions": [
    {
      "candidate_surface": "systematic review",
      "resolved_canonical": "Systematic Review",
      "decision": "linked",
      "scores": {
        "novelty": 0.45,
        "connectivity": 0.88,
        "specificity": 0.7,
        "link_intent": 0.8
      }
    },
    {
      "candidate_surface": "information retrieval",
      "resolved_canonical": "Information Retrieval",
      "decision": "linked",
      "scores": {
        "novelty": 0.4,
        "connectivity": 0.85,
        "specificity": 0.65,
        "link_intent": 0.78
      }
    },
    {
      "candidate_surface": "endometriosis recurrence",
      "resolved_canonical": "Endometriosis Recurrence",
      "decision": "linked",
      "scores": {
        "novelty": 0.75,
        "connectivity": 0.6,
        "specificity": 0.85,
        "link_intent": 0.82
      }
    },
    {
      "candidate_surface": "gonadotropin-releasing hormone agonists",
      "resolved_canonical": "GnRH Agonists",
      "decision": "linked",
      "scores": {
        "novelty": 0.7,
        "connectivity": 0.65,
        "specificity": 0.8,
        "link_intent": 0.79
      }
    }
  ]
}
-->

# Computational-Assisted Systematic Review and Meta-Analysis (CASMA): Effect of a Subclass of GnRH-a on Endometriosis Recurrence

## ğŸ“‹ ë©”íƒ€ë°ì´í„°

**Links**: [[daily_digest_20250923|20250923]] [[categories/cs.CL|cs.CL]]
**PDF**: [Download](https://arxiv.org/pdf/2509.16599.pdf)
**Category**: cs.CL
**Published**: 2025-09-23
**ArXiv ID**: [2509.16599](https://arxiv.org/abs/2509.16599)

## ğŸ”— ìœ ì‚¬í•œ ë…¼ë¬¸
- [[2025-09-23/Enhancing Study-Level Inference from Clinical Trial Papers via Reinforcement Learning-Based Numeric Reasoning_20250923|Enhancing Study-Level Inference from Clinical Trial Papers via Reinforcement Learning-Based Numeric Reasoning]] (81.2% similar)
- [[2025-09-23/Can Agents Judge Systematic Reviews Like Humans? Evaluating SLRs with LLM-based Multi-Agent System_20250923|Can Agents Judge Systematic Reviews Like Humans? Evaluating SLRs with LLM-based Multi-Agent System]] (77.6% similar)
- [[2025-09-17/Combating Biomedical Misinformation through Multi-modal Claim Detection and Evidence-based Verification_20250917|Combating Biomedical Misinformation through Multi-modal Claim Detection and Evidence-based Verification]] (77.1% similar)
- [[2025-09-23/Medical priority fusion_ achieving dual optimization of sensitivity and interpretability in nipt anomaly detection_20250923|Medical priority fusion: achieving dual optimization of sensitivity and interpretability in nipt anomaly detection]] (77.1% similar)
- [[2025-09-17/Combining Evidence and Reasoning for Biomedical Fact-Checking_20250917|Combining Evidence and Reasoning for Biomedical Fact-Checking]] (77.1% similar)

## ğŸ·ï¸ ì¹´í…Œê³ ë¦¬í™”ëœ í‚¤ì›Œë“œ
**ğŸ§  Broad Technical**: [[keywords/Information Retrieval|Information Retrieval]]
**ğŸ”— Specific Connectable**: [[keywords/Systematic Review|Systematic Review]]
**âš¡ Unique Technical**: [[keywords/Endometriosis Recurrence|Endometriosis Recurrence]], [[keywords/GnRH Agonists|GnRH Agonists]]

## ğŸ“‹ ì €ì ì •ë³´

**Authors:** 

## ğŸ“„ Abstract (ì›ë¬¸)

arXiv:2509.16599v1 Announce Type: new 
Abstract: Background: Evidence synthesis facilitates evidence-based medicine. Without information retrieval techniques, this task is impossible due to the vast and expanding literature. Objective: Building on prior work, this study evaluates an information retrieval-driven workflow to enhance the efficiency, transparency, and reproducibility of systematic reviews. We use endometriosis recurrence as an ideal case due to its complex and ambiguous literature. Methods: Our hybrid approach integrates PRISMA guidelines with computational techniques. We applied semi-automated deduplication to efficiently filter records before manual screening. This workflow synthesized evidence from randomised controlled trials on the efficacy of a subclass of gonadotropin-releasing hormone agonists (GnRH'as). A modified splitting method addressed unit-of-analysis errors in multi-arm trials. Results: Our workflow efficiently reduced the screening workload. It took only 11 days to fetch and filter 812 records. Seven RCTs were eligible, providing evidence from 841 patients in 4 countries. The pooled random-effects model yielded a Risk Ratio (RR) of 0.64 (95% CI (0.48 to 0.86)), with non-significant heterogeneity ($I^2=0.00\%$, $\tau=0.00$); i.e., a 36% reduction in endometriosis recurrence. Sensitivity analyses and bias assessments supported the robustness of our findings. Conclusion: This study demonstrates an information-retrieval-driven workflow for medical evidence synthesis. Our approach yields valuable clinical results while providing a framework for accelerating the systematic review process. It bridges the gap between clinical research and computer science and can be generalized to other complex systematic reviews.

## ğŸ“ ìš”ì•½

ì´ ì—°êµ¬ëŠ” ì •ë³´ ê²€ìƒ‰ ê¸°ë°˜ ì›Œí¬í”Œë¡œìš°ë¥¼ í†µí•´ ì²´ê³„ì  ë¬¸í—Œê³ ì°°ì˜ íš¨ìœ¨ì„±, íˆ¬ëª…ì„±, ì¬í˜„ì„±ì„ í–¥ìƒì‹œí‚¤ëŠ” ë°©ë²•ì„ í‰ê°€í•©ë‹ˆë‹¤. ë³µì¡í•œ ë¬¸í—Œì„ ê°€ì§„ ìê¶ë‚´ë§‰ì¦ ì¬ë°œì„ ì‚¬ë¡€ë¡œ ì‚¼ì•„, PRISMA ì§€ì¹¨ê³¼ ì»´í“¨íŒ… ê¸°ìˆ ì„ ê²°í•©í•œ í•˜ì´ë¸Œë¦¬ë“œ ì ‘ê·¼ë²•ì„ ì‚¬ìš©í–ˆìŠµë‹ˆë‹¤. ë°˜ìë™ ì¤‘ë³µ ì œê±°ë¡œ 812ê°œì˜ ê¸°ë¡ì„ 11ì¼ ë§Œì— í•„í„°ë§í•˜ê³ , 4ê°œêµ­ 841ëª…ì˜ í™˜ìë¥¼ ëŒ€ìƒìœ¼ë¡œ í•œ 7ê°œì˜ ë¬´ì‘ìœ„ ëŒ€ì¡°êµ° ì‹œí—˜(RCT)ì„ ë¶„ì„í–ˆìŠµë‹ˆë‹¤. ê²°ê³¼ì ìœ¼ë¡œ, GnRH ì‘ìš©ì œì˜ íš¨ëŠ¥ì— ëŒ€í•œ í•©ì„± ì¦ê±°ëŠ” ìê¶ë‚´ë§‰ì¦ ì¬ë°œì„ 36% ê°ì†Œì‹œì¼°ìœ¼ë©°, ì—°êµ¬ì˜ ê°•ê±´ì„±ì„ ë’·ë°›ì¹¨í•˜ëŠ” ë¯¼ê°ë„ ë¶„ì„ê³¼ í¸í–¥ í‰ê°€ë„ ìˆ˜í–‰ë˜ì—ˆìŠµë‹ˆë‹¤. ì´ ì—°êµ¬ëŠ” ì˜ë£Œ ì¦ê±° í•©ì„±ì„ ìœ„í•œ ì •ë³´ ê²€ìƒ‰ ê¸°ë°˜ ì›Œí¬í”Œë¡œìš°ì˜ ìœ ìš©ì„±ì„ ì…ì¦í•˜ë©°, ì„ìƒ ì—°êµ¬ì™€ ì»´í“¨í„° ê³¼í•™ ê°„ì˜ ê²©ì°¨ë¥¼ ì¤„ì´ê³  ë‹¤ë¥¸ ë³µì¡í•œ ì²´ê³„ì  ë¬¸í—Œê³ ì°°ì—ë„ ì ìš©ë  ìˆ˜ ìˆëŠ” í‹€ì„ ì œê³µí•©ë‹ˆë‹¤.

## ğŸ¯ ì£¼ìš” í¬ì¸íŠ¸

- 1. ì •ë³´ ê²€ìƒ‰ ê¸°ë°˜ ì›Œí¬í”Œë¡œìš°ë¥¼ í†µí•´ ì²´ê³„ì  ë¬¸í—Œ ê³ ì°°ì˜ íš¨ìœ¨ì„±, íˆ¬ëª…ì„±, ì¬í˜„ì„±ì„ í–¥ìƒì‹œì¼°ìŠµë‹ˆë‹¤.
- 2. ë³¸ ì—°êµ¬ëŠ” ë³µì¡í•˜ê³  ëª¨í˜¸í•œ ë¬¸í—Œì„ ê°€ì§„ ìê¶ë‚´ë§‰ì¦ ì¬ë°œì„ ì‚¬ë¡€ë¡œ ì‚¼ì•„ ì—°êµ¬ë¥¼ ì§„í–‰í–ˆìŠµë‹ˆë‹¤.
- 3. PRISMA ê°€ì´ë“œë¼ì¸ê³¼ ì»´í“¨íŒ… ê¸°ìˆ ì„ í†µí•©í•œ í•˜ì´ë¸Œë¦¬ë“œ ì ‘ê·¼ë²•ì„ ì‚¬ìš©í•˜ì—¬ ê¸°ë¡ì„ í•„í„°ë§í•˜ê³  ì¦ê±°ë¥¼ í•©ì„±í–ˆìŠµë‹ˆë‹¤.
- 4. 11ì¼ ë§Œì— 812ê°œì˜ ê¸°ë¡ì„ í•„í„°ë§í•˜ì—¬ 7ê°œì˜ ë¬´ì‘ìœ„ ëŒ€ì¡° ì‹œí—˜(RCT)ì„ ì„ ì •í–ˆìœ¼ë©°, ì´ëŠ” 4ê°œêµ­ì˜ 841ëª…ì˜ í™˜ìë¡œë¶€í„° ì¦ê±°ë¥¼ ì œê³µí–ˆìŠµë‹ˆë‹¤.
- 5. ì—°êµ¬ ê²°ê³¼, ìê¶ë‚´ë§‰ì¦ ì¬ë°œ ìœ„í—˜ë¹„ê°€ 0.64ë¡œ 36% ê°ì†Œí–ˆìœ¼ë©°, ë¯¼ê°ë„ ë¶„ì„ê³¼ í¸í–¥ í‰ê°€ë¥¼ í†µí•´ ê²°ê³¼ì˜ ê²¬ê³ ì„±ì„ í™•ì¸í–ˆìŠµë‹ˆë‹¤.


---

*Generated on 2025-09-24 03:15:14*